Literature DB >> 11252611

Nonparametric estimation in a cure model with random cure times.

R A Betensky1, D A Schoenfeld.   

Abstract

Acute respiratory distress syndrome (ARDS) is a life-threatening acute condition that sometimes follows pneumonia or surgery. Patients who recover and leave the hospital are considered to have been cured at the time they leave the hospital. These data differ from typical data in which cure is a possibility: death times are not observed for patients who are cured and cure times are observed and vary among patients. Here we apply a competing risks model to these data and show it to be equivalent to a mixture model, the more common approach for cure data. Further, we derive an estimator for the variance of the cumulative incidence function from the competing risks model, and thus for the cure rate, based on elementary calculations. We compare our variance estimator to Gray's (1988, Annals of Statistics 16, 1140-1154) estimator, which is based on counting process theory. We find our estimator to be slightly more accurate in small samples. We apply these results to data from an ARDS clinical trial.

Entities:  

Mesh:

Year:  2001        PMID: 11252611     DOI: 10.1111/j.0006-341x.2001.00282.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Estimating the case fatality rate using a constant cure-death hazard ratio.

Authors:  Zheng Chen; Kohei Akazawa; Tsuyoshi Nakamura
Journal:  Lifetime Data Anal       Date:  2009-05-21       Impact factor: 1.588

2.  A class of semiparametric cure models with current status data.

Authors:  Guoqing Diao; Ao Yuan
Journal:  Lifetime Data Anal       Date:  2018-02-08       Impact factor: 1.588

3.  Multiple imputation methods for nonparametric inference on cumulative incidence with missing cause of failure.

Authors:  Minjung Lee; James J Dignam; Junhee Han
Journal:  Stat Med       Date:  2014-07-04       Impact factor: 2.373

4.  Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies.

Authors:  David Schoenfeld
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.